EC. Quality of life. THOVLEN: Targeted herpes-virus derived oncolytic vectors for liver cancer European Network (2005-2008)

EC. Quality of life. COMPUVAC: Rational design and standardized evaluation of novel genetic vaccines (2005-2008)

Greek General Secretariat of Science and Technology. Bilateral S&T Collaboration Program Greece – France PLATO 3: HCV dependent hepatocellular carcinoma: Development of RNAi approach against HCV replication based on the use of novel HSV-1 amplicon viral vectors (2004- 2006) (Dr Mavromara –Georgopoulou)

Institut Pasteur Hellenique, Research Grant: Study of the biological properties of core/core+1 proteins of HCV by the use of transgenic mice (collaboration with Dr L Probert, Molecular Genetics Laboratory, IPH) (2004-2006)

IP Paris: International Network of Pasteur. ACIP III: Etude des genotypes du virus de l’hepatite C en Asie du Sud Est (Cambodge et Vietnam) et developpement de methodes diagnostiques specifiques (2003-2005)

IP Paris: Διεθνές Δίκτυο Pasteur. PTR: Implications of HCV diversity in the diagnosis and pathogenesis of virus infection (2003-2005)

IP Paris: Διεθνές Δίκτυο Pasteur. INSERM: ATC-Hépatite C: Vers la rèsolution de controversies concernant les mècanismes de la traduction chez le virus de l’hépatite C: conséquences en pathologie humaine (2004-2005)

Hellenic Centre for Infectious Diseases Control, Ministry of Health and Welfare. KEEL-2: Study of the biological properties of the HCV core+1/F protein (2003-2004)

EC. Quality of life. EUROAMP: European (EURO) Network for Development of Novel Safe Vaccines Based on New Generation Amplicons (AMP) and Other Defective HSV – 1 Derived Vectors as Foreign Antigen Delivery Systems (2000-2004)

Greek General Secretariat of Science and Technology. Bilateral S&T Collaboration Program Greece – France PLATO 2: Construction of herpes-based viral vectors for the development of vaccines against hepatitis C (2002-2004)

Greek General Secretariat of Science and Technology. Carrier opportunity program in Greece for Greek speaking researchers from abroad: Research on the molecular pathogenesis and treatment of viral infections and viral induced carcinogenesis in humans (1999 – 2001)

Greek General Secretariat of Science and Technology. Bilateral S&T Collaboration Program Greece – Italy: Expression of HCV proteins by the use of HSV based recombinant viral vectors; development of vaccines against HCV (1999-2001)

Greek General Secretariat of Science and Technology. Bilateral S&T Collaboration Program Greece – France PLATO 1: Development and use of HSV-based amplicon vectors for the expression of HCV structural protein (1999-2001)

Greek General Secretariat of Science and Technology. PENED 99 II: Cloning of genes expressing regulatory proteins of biotechnological importance application of expression systems for the production of heterologous peptides(11/2000 – 9/2001)

IP Paris: International Network of Pasteur. ACIP II: Recherche des recombinants chez des virus ARN de polarite positive (enterovirus et virus de l’hepatite C) (1998 – 2000)

INCO-COPERNICUS: Improvement of surveillance and prevention of HCV infection (1998-2000)

EC. BIOTECH: European Union Network for Evaluation of Nucleic Acid-Based Vaccines for Induction of Antiviral Immunity (Dec.1996 – 2000)

EC. TMR: European Union network for investigation of dendritic immunotherapy for induction of anti-viral and anti-tumor immunity and transplantation tolerance (Oct. 1996 – 2000)

IP Paris: International Network of Pasteur. ACIP I: Etude Comparative d’epidemiologie moleculaire des infections par l’hepatitis C en Europe et l’Iran (1997 – 1999)

Greek General Secretariat of Science and Technology. PENED I: Production of viral recombinant antigens of human HPV from eukaryotic cells for diagnostic purposes with the use of viral systems of expression. Development of immunodiagnostics (1996 – 1998)

EC. BIOMED: Molecular approaches to analyze Hepatitis C virus replication for the development of effective therapy and vaccines (1996 – 1998)

Hellenic Centre for Infectious Diseases Control, Ministry of Health and Welfare. KEEL-1: Cellular genes and proteins related to the action of interferon in HCV, HIV, HCV/HIV infections (2003-2005) (Responsible Researcher Dr U. Georgopoulou)

ΙP Paris: International Network of Pasteur. INSERM: ATC-Hépatite C: Utilisation de nouveaux outils moleculaires pour l'enrichissement d'hepatocytes primaires humains infectés par le virus de l'hepatite C: approches pour l'etude des interactions moléculaires entre le VHC et la cellule hôte, en presence ou non d'un traitement antiviral (2003-2005) (Responsible Researcher Dr H. Boleti)

Greek General Secretariat of Science and Technology, in the context of the Operational program "COMPETITIVENESS" – “Creation of communication channels for academics, research/technology entities and enterprises with common scientific interests” Applications of Light Microscopy in Biomedical Research and Diagnosis (2004-2005) (Responsible Researcher Dr H. Boleti)

Institut Pasteur Hellenique, Research Grant: Development of molecular and cellular tools for the study of the Biochemical properties of the NS4B HCV non-stuctural protein IPH) (2002-2004) (Responsible Researcher Dr H. Boleti)